$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Oct 24, 2025)
$9.53M
Market Cap
-
P/E Ratio
-9.16
EPS
$12.54
52 Week High
$1.91
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
In8bio, Inc. is a New York-based clinical-stage biotechnology company focused on advancing innovative therapies for cancer treatment through the development of genetically modified gamma-delta T cells. By leveraging its expertise in both autologous and allogeneic cell therapies, the company is effectively targeting solid tumors and positioning itself as a leader in the immuno-oncology sector. With a strong pipeline of proprietary treatments and a dedication to addressing significant unmet needs in cancer care, In8bio aims to deliver transformative solutions that could reshape the landscape of oncology therapeutics.
BYND
WGRX
VHAI
YYAI
F
INTC
DVLT
CGBS
ASST
NVDA
BITF
AAL
TSLA
DNN
RGTI
NEUP
ADTX
T
PLUG
RIG
SCNX
NOK
AMD
QBTS
RF
CAN
LAES
SOFI
NEHC
GRAB
QS
TLRY
ADAP
SNAP
CIFR
AIRE
JOBY
BAC
RXRX
NIO
IREN
BTBT
RR
AMC
PLTR
NVTS
CLOV
UUUU
DFLI
RVPH
MARA
APLD
PBR
KDLY
WU
GOOGL
SOUN
IONQ
PFE
WULF
VZ
LAZR
SKYQ
MU
JBLU
SMCI
CLSK
WBD
LUMN
HOOD
BYND
WGRX
VHAI
YYAI
F
INTC
DVLT
CGBS
ASST
NVDA
BITF
AAL
TSLA
DNN
RGTI
NEUP
ADTX
T
PLUG
RIG
SCNX
NOK
AMD
QBTS
RF
CAN
LAES
SOFI
NEHC
GRAB
QS
TLRY
ADAP
SNAP
CIFR
AIRE
JOBY
BAC
RXRX
NIO
IREN
BTBT
RR
AMC
PLTR
NVTS
CLOV
UUUU
DFLI
RVPH
MARA
APLD
PBR
KDLY
WU
GOOGL
SOUN
IONQ
PFE
WULF
VZ
LAZR
SKYQ
MU
JBLU
SMCI
CLSK
WBD
LUMN
HOOD